For example, increased expression of the RTKs Met and epidermal growth factor receptor (Egfr) are associated with basal and triple-negative breast cancers [13]-[15], and, at least in cell line models, the basal and claudin-low subtypes are characterised by a prominent Src family kinase (SFK)–governed network [16],[17]. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.